Hospital De Santa Maria E.P.E.

Az itteni vizsgálatok

Miről szól a helyszín 38 vizsgálata, a regiszteri adatlapjaik szerint.

Betegségek

• Akut mieloid leukémia (AML)3 vizsgálat
• Atópiás dermatitisz (ekcéma)3 vizsgálat
• Colitis ulcerosa2 vizsgálat
• Hólyagrák2 vizsgálat
• Mielóma multiplex2 vizsgálat
• Migrén2 vizsgálat
• Pikkelysömör2 vizsgálat
• Rheumatoid arthritis2 vizsgálat
• Vastagbélrák2 vizsgálat
• Amiloidózis1 vizsgálat
• Arthritis psoriatica1 vizsgálat
• Áttétes emlőrák1 vizsgálat
• és még 17

Fázis

• 3. fázis26 vizsgálat
• 2. fázis7 vizsgálat
• 4. fázis3 vizsgálat
• 2/3. fázis2 vizsgálat

Állapot

• Lezárult14 vizsgálat
• Fut, nem toboroz12 vizsgálat
• Toboroz8 vizsgálat
• Még nem toboroz3 vizsgálat
• Visszavonták1 vizsgálat

Fő szponzor

• AbbVie6 vizsgálat
• Sanofi5 vizsgálat
• Hoffmann-La Roche3 vizsgálat
• Janssen Research & Development, LLC2 vizsgálat
• Queen Mary University Of London2 vizsgálat
• és még 20

Futó vizsgálatok

• Még nem toboroz

  A study to compare heart failure medicines in one combined pill with usual care.

  2026-526510-90-00· 3. fázis· Institut De Recherches Internationales Servier IRIS· Forrás

• Toboroz

  A study to evaluate the safety and efficacy of oral decitabine plus ivosidenib in newly diagnosed adult patients with acute myeloid leukemia older than 60 years and/or inelegible for standard induction chemotherapy

  2025-523238-17-00· 2. fázis· Fundacion PETHEMA· Forrás

• Még nem toboroz

  HOVON 168:Study on epcoritamab in frail patients with diffuse large B-Cell lymphoma (DLBCL) who have not been treated before

  2025-524230-25-00· 2. fázis· Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting· Forrás

• Toboroz

  RANDOMISED, MULTICENTRE, DOUBLE-BLIND CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF MONTELUKAST VS. PLACEBO IN PATIENTS WITH EROSIVE/INFLAMMATORY OSTEOARTHRITIS OF THE HANDS. MOTHER Study.

  2025-521802-17-00· 3. fázis· Farmalider S.A.· Forrás

• Toboroz

  Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

  NCT07007312· 3. fázis· Kura Oncology, Inc.· Forrás

• Toboroz

  IMPACT-AML: A Randomized Pragmatic Clinical Trial for Relapsed or Refractory Acute Myeloid Leukemia.

  NCT06713837· 3. fázis· Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS· Forrás

• Toboroz

  3TR-PARTNER-RA

  2024-511470-79-00· 4. fázis· Queen Mary University Of London· Forrás

• Toboroz

  Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

  NCT06548542· 2. fázis· AbbVie· Forrás

• Fut, nem toboroz

  Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma

  NCT06158841· 3. fázis· AbbVie· Forrás

• Fut, nem toboroz

  Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma

  NCT06191744· 3. fázis· Genmab· Forrás

• Fut, nem toboroz

  A Study to Evaluate ABP 206 Compared with OPDIVO® (Nivolumab) in Subjects with Unresectable or Metastatic Melanoma

  2023-503288-40-00· 3. fázis· Amgen Inc.· Forrás

• Toboroz

  Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients

  NCT06317805· 4. fázis· AOP Orphan Pharmaceuticals AG· Forrás

• Toboroz

  The 3TR Molecular Pathobiology-Driven Precision Therapy in RA (3TR Precis-The-RA) study

  2022-502021-18-00· 4. fázis· Queen Mary University Of London· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome

  NCT05946941· 3. fázis· Bristol-Myers Squibb· Forrás

• Toboroz

  Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer

  NCT05855200· 3. fázis· GlaxoSmithKline· Forrás

• Fut, nem toboroz

  A Study to Investigate Subcutaneous Isatuximab in Combination With Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma

  NCT05704049· 2. fázis· Sanofi· Forrás

• Fut, nem toboroz

  A Study of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants With BCG-naïve High-risk Non-muscle Invasive Bladder Cancer (HR-NMIBC)

  NCT05714202· 3. fázis· Janssen Research & Development, LLC· Forrás

• Fut, nem toboroz

  Study of XL092 + Atezolizumab vs Regorafenib in Participants With Metastatic Colorectal Cancer

  NCT05425940· 3. fázis· Exelixis· Forrás

• Fut, nem toboroz

  Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate to Severe Atopic Dermatitis Clinical Trials

  NCT05492578· 2/3. fázis· Sanofi· Forrás

• Fut, nem toboroz

  A Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Hormone-Sensitive Prostate Cancer

  NCT04557059· 3. fázis· Janssen Pharmaceutica N.V., Belgium· Forrás

• Fut, nem toboroz

  A Study Evaluating the Efficacy and Safety of Giredestrant Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Participants With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (persevERA Breast Cancer)

  NCT04546009· 3. fázis· Hoffmann-La Roche· Forrás

• Fut, nem toboroz

  A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or Intolerance to at Least One Disease Modifying Anti-Rheumatic Drug (DMARD) Therapy

  NCT03675308· 3. fázis· AbbVie· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Long-Term Safety and Efficacy of Upadacitinib (ABT-494) in Participants With Ulcerative Colitis (UC)

  NCT03006068· 3. fázis· AbbVie· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Akut mieloid leukémia (AML)3 toboroz
• Rheumatoid arthritis2 toboroz
• Crohn-betegség1 toboroz
• Diffúz nagy B-sejtes limfóma (DLBCL)1 toboroz
• Magas vérnyomás1 toboroz
• Osteoarthritis1 toboroz
• Pulmonális artériás hipertónia1 toboroz
• Sjögren-szindróma1 toboroz
• Szívelégtelenség1 toboroz

Lezárt vizsgálatok

• Lezárult

  A Phase IIb, Multicentre, Randomised, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Efficacy and Safety of Dirocaftor/Posenacaftor/Nesolicaftor in Subjects with Cystic Fibrosis Aged 18 Years or Older (CHOICES)

  2022-500410-26-01· 2. fázis· University Medical Center Utrecht· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Treatment Response and Safety of Two Dose Regimens of Subcutaneous Amlitelimab Compared With Treatment Withdrawal in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis

  NCT06407934· 3. fázis· Sanofi· Forrás

• Lezárult

  Study of Oral Atogepant Tablets to Assess Safety and Efficacy in Adult Participants With Migraine

  NCT06241313· 3. fázis· AbbVie· Forrás

• Toboroz

  An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

  NCT05835310· 3. fázis· AstraZeneca· Forrás

• Lezárult

  A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis (COAST 2)

  NCT06181435· 3. fázis· Sanofi· Forrás

• Lezárult

  A Study to Evaluate Efficacy and Safety of SAR441566 in Adults With Plaque Psoriasis

  NCT06073119· 2. fázis· Sanofi· Forrás

• Lezárult

  Comparative Study of Oral Atogepant Versus Oral Topiramate to Assess Adverse Events in Adult Participants With Migraine

  NCT05748483· 3. fázis· AbbVie· Forrás

• Fut, nem toboroz

  GENERATION HD2. A Study to Evaluate the Safety, Biomarkers, and Efficacy of Tominersen Compared With Placebo in Participants With Prodromal and Early Manifest Huntington's Disease

  NCT05686551· 2. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1

  NCT05507203· 3. fázis· Abivax S.A.· Forrás

• Lezárult

  A Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With Dermatomyositis

  NCT05437263· 3. fázis· Priovant Therapeutics, Inc.· Forrás

• Lezárult

  A Study to Investigate the Safety and Efficacy of RO7204239 in Combination With Risdiplam (RO7034067) in Participants With Spinal Muscular Atrophy

  NCT05115110· 2/3. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  A study to test long-term safety of Iclepertin in people with schizophrenia who took part in a previous CONNEX study

  2024-511560-93-00· 3. fázis· Boehringer Ingelheim International GmbH· Forrás

• Fut, nem toboroz

  A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder

  NCT04658862· 3. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  HELIOS-A: A Study of Vutrisiran (ALN-TTRSC02) in Patients With Hereditary Transthyretin Amyloidosis (hATTR Amyloidosis)

  NCT03759379· 3. fázis· Alnylam Pharmaceuticals· Forrás

• Lezárult

  Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs Placebo Plus Chemotherapy as Neoadjuvant Therapy and Pembrolizumab vs Placebo as Adjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC) (MK-3475-522/KEYNOTE-522)

  NCT03036488· 3. fázis· Merck Sharp & Dohme LLC· Forrás